drugset / Trial / NCT06437054
Verification of the Efficacy/Safety of the Mixed Drug Injectable Delivery Vehicle for Treating Intractable Hearing Loss
RandomizedParallel-groupDouble-blindTreatment
Summary
This study is a prospective, randomized pilot study. To verify an efficacy/safety of the mixed drug injectable delivery vehicle for treating intractable hearing loss. Hearing test, endoscopy of tympanic membrane and CT scans will be conducted after intratympanic treatment for evaluation.
Timeline
- Start
- 2026-12-15
- Primary completion
- 2026-12-15
- Completion
- 2028-09-30
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Hyaluronic Acid | Other / unclassified | 20 mg | Intrathecal |
| Background | Dexamethasone | Small molecule | 5 mg/ml | Intrathecal |